Exelixis
EXEL
33,27 €
Share price
-0.97%
Change (1 day)
53.51%
Change (1 year)
Categories
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.
Exelixis (EXEL) - Cost to borrow shares
Latest borrow fee for Exelixis (EXEL) shares on Interactive Brokers: 0.3968% (annualized)
Shares available to borrow: 8200000The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.
Exelixis (EXEL) - cost to borrow in the last 7 days chart
Exelixis (EXEL) - number of shares available to borrow in the last 7 days
Exelixis (EXEL) - cost to borrow from 2025 to 2023
Exelixis (EXEL) - number of shares available to borrow from 2025 to 2023
Cost to borrow for shares of similar companies or competitors
| Company | Cost to borrow (% year) | Shares available | Country |
|---|---|---|---|
 | 0.5542% | 0.7 M | 🇬🇧 UK |
 | 0.2656% | 1.8 M | 🇫🇷 France |
 | 0.25% | 10 M | 🇺🇸 USA |
 | 0.2771% | 10 M | 🇺🇸 USA |
 | 0.2932% | 4.8 M | 🇺🇸 USA |
 | 0.4081% | 10 M | 🇺🇸 USA |
 | 0.5825% | 10 M | 🇺🇸 USA |
 | 1.3767% | 0.45 M | 🇺🇸 USA |